Cisplatin ld50 in mice

Author: pudw

August undefined, 2024

WebFrequency and doses of cisplatin in nude mice. We would like to test our experimental treatment of cancer on nude mice with xenograft tumor, one of our control groups is cisplatin. Our... WebJun 30, 1983 · The embryonic LD50 for mice was 5.24 mg/kg. An increase in the incidence of growth retardation or gross malformations was not discernable in the surviving fetuses with the number of dams used in this study. Cisplatin is highly embryolethal in rats and mice at dosages well below the adult therapeutic dosage in humans.

Cisplatin-Induced Rodent Model of Kidney Injury

WebFeb 28, 2024 · One of the main problems in chemotherapy using platinum drugs as anticancer agents is the resistance phenomenon. Synthesizing and evaluating valid alternative compounds is challenging. This review focuses on the last two years of progress in the studies of platinum (II)- and platinum (IV)-based anticancer complexes. In … earchar

Cisplatin promotes the expression level of PD-L1 in the ...

WebDec 5, 2024 · Cisplatin dosage represented the mouse dose equivalent of 75 mg/m 2 IP dose in humans. Mice received 3 treatments, every 2 weeks, starting 14 days after tumor challenge. WebMar 15, 2016 · Cisplatin at 25 mg/kg in PBS (200 μl/animal) was administered by an intraperitoneal injection. Seventy-two hours after cisplatin injection, these mice were euthanized. Another cohort of mice received either 7 or 9 mg/kg cisplatin administered by an intraperitoneal injection once a week for 4 wk. WebSep 1, 2024 · The serum of nutlin-3a or cisplatin-treated mice was obtained 4 h after LPS injection. Tissues of nutlin-3a or cisplatin-treated mice were obtained 12 h after LPS injection. Survival of mice was monitored after an i.p. injection of LPS (60 mg/kg) or E. coli (1 × 10 8 CFU). ear chapman point

Embryotoxicity of cisplatin in rats and mice - ScienceDirect

Combination therapy of cisplatin with cilastatin enables

WebOct 1, 2024 · Cisplatin is a potent chemotherapeutic used for the treatment of many types of cancer. However, its dose-limiting side effect is nephrotoxicity leading to acute kidney injury (AKI). Patients who develop AKI have an increased risk of mortality and are more likely to develop chronic kidney disease (CKD). WebThese human neoplastic cells are also more susceptible than peripheral blood mononuclear cells (PBMCs) toward the tested compounds. Using C57BL/6 mice an LD50 of 55mgkg(-1) was determined for complex (2), suggesting that this compound is almost four times less toxic than cisplatin (LD50=14.5mgkg(-1)). earc fire tvWebSingle dose of cisplatin (16 mg/kg) in aging and young mice resulted in 100% mortality of 24-month-old female mice and 40% mortality of 4-8-week-old mice within 7 days after administration [148, 149]. Increased … earchar图

"WebMouse IP LD50 40 mg/kg No data available. Material Name: Cisplatin Injection Sodium chloride Molecular Formula: Rat Oral LD50 3000 mg/kg Mixture Mouse Oral LD50 4000 mg/kg Version: 1.0 Cisplatin Mannitol Molecular Weight: Rat Oral LD 50 13500 mg/kg Mixture Rat Oral LD 50 25.8 mg/kg " - Cisplatin ld50 in mice

Cisplatin ld50 in mice

C57BL/6 mice require a higher dose of cisplatin to induce …

WebDetermination of LPS LD50 in C57BL/6 mice. The mice were challenged i.p. with different doses of LPS to monitor the survival rates and organ injury to determine the LD50. (a) Mice were... WebNude mice were divided into 3 groups (etoposide, cisplatin and MTX-group), 7 to 9 per group and received drug treatment which started when their tumor grew to 100 approximately 300 mm3 in volume. All drugs were intraperitoneally administrated to nude mice (each drug: 1/4 mouse LD50 dose X3, weekly).

Did you know?

WebDec 21, 2024 · Mice were divided into a control group, cisplatin-treated group, and cisplatin + myo-inositol-treated group, which were treated with cisplatin or myo-inositol accordingly. Mice received intraperitoneal injection of cisplatin at a dose of 25 mg/kg, and they were sacrificed by cervical dislocation three days later. WebMaterial Name: Cisplatin Solution for Injection - 0.5 and 1 mg/ml Trade Name: Platamine; Cisplatino; Cisplatine; Platiblastin; Plastisil; Platiblastin S Chemical Family: Mixture Intended Use: Pharmaceutical product used as Antineoplastic 2. COMPOSITION/INFORMATION …

WebAug 6, 2024 · The mice in cisplatin groups were intraperitoneally administered (2 mg/kg cisplatin dissolved in 0.9% saline) with 0.1 ml of cisplatin. The mice in the normal control (NC) group were intraperitoneally injected with physiological saline. The … WebJun 12, 2024 · Effects of cisplatin (3.5 mg/kg at 72‐h intervals) on UM‐SCC‐22A (A) versus UM‐SCC‐47 (B)‐derived xenograft tumors grown in the flanks of SCID mice were measured at days 0 and 14 (n = 5–8 mice/group, and *P < 0.05 by unpaired Student's t‐test).After the measurement of tumor volumes, CerS1‐6 mRNAs were measured in extracted tumor …

WebApr 25, 2014 · Cisplatin (dichlorodiamino platinum) is an inorganic platinum-based chemotherapeutic agent that is widely used in the treatment of a variety of solid malignant tumors such as head and neck, lung, testis, ovarian, and bladder cancers [9]. WebOct 1, 2024 · In addition, significant immune cell infiltration was observed in the kidney after four doses of 9 mg/kg cisplatin, contrary to what has been previously reported. These results indicate that multiple strains of mice can be used with our repeated low-dose …

WebApr 13, 2024 · Head and neck squamous cell carcinoma (HNSCC) is among the most severe and complex malignant diseases with a high level of heterogeneity and, as a result, a wide range of therapeutic responses ...

WebDec 23, 2024 · In humans, the volume of peritoneal fluid ranges from 50 to 75 ml ( 7 ), whereas in mice its volume ranges between 0.02 and 0.1 ml ( 8 ). In addition, the peritoneal fluid contains leukocytes and antibodies to fight off infections, and plasma proteins at concentration that is about 50% of what is found in plasma ( 9 ). css before ieWebHowever, the immune tolerance limits the effect of chemotherapeutic drugs. Therefore, the mechanism of cisplatin in promoting PD-L1 expression by YAP1 was investigated in the present study, and we found that cisplatin increased the expression level of YAP1 in the mouse liver with H22 cells. css before horizontal lineWebThe LD 50 was 8.6 mg/kg for free cisplatin and 103.4 mg/kg for cisplatin-loaded nanoparticles, as shown in Table 3. Therefore, compared with free cisplatin, the nanopar- ticles loaded with... css before lineWebAug 14, 2024 · The vehicle control mice were injected with normal saline (cisplatin group) or corn oil (AAI group). After collecting the blood and urine samples from each mouse, the levels of nephrotoxic... ear channel blockageWebMouse IP LD50 40 mg/kg No data available. Material Name: Cisplatin Injection Sodium chloride Molecular Formula: Rat Oral LD50 3000 mg/kg Mixture Mouse Oral LD50 4000 mg/kg Version: 1.0 Cisplatin Mannitol Molecular Weight: Rat Oral LD 50 13500 mg/kg … ear chalk hearing testWebMaterial Name: Cisplatin Solution for Injection - 0.5 and 1 mg/ml Revision date: 02-Jan-2007 Page 3 of 7 Version: 1.1 7. HANDLING AND STORAGE ... Rat Oral LD50 3000 mg/kg Sodium chloride Eye Irritation Rabbit Moderate Mouse Oral LD 50 4000 mg/kg Mouse Oral LD 50 32.7 mg/kg ... css before no contentWebCisplatin was positive in a battery of in vitro and in vivo genotoxicity assays to detect mutagenic and clastogenic activity. Carcinogenicity Cisplatin has been shown to be carcinogenic in mice and rats. Secondary malignancies have been reported in cancer … earch architecture